Date published: 2025-10-10

00800 4573 8000

SCBT Portrait Logo
Seach Input

TAJ-β Inibidores

TAJ-β inhibitors represent a specialized class of chemical compounds designed to specifically inhibit the function of the TAJ-β protein, a molecule known to play a role in various cellular regulatory pathways. TAJ-β inhibitors operate by binding to the active sites or key functional domains of the TAJ-β protein, thus preventing its normal activity within the cell. These inhibitors are often developed to fit the precise structural features of the TAJ-β protein, ensuring that they can effectively block its interactions or catalytic actions. The inhibitors may target different regions of the protein, such as its binding pockets or allosteric sites, depending on their mode of action and the specific mechanism by which they interfere with the protein's function. The chemical design of TAJ-β inhibitors is crucial for achieving a high degree of specificity, ensuring they interact with TAJ-β while minimizing interaction with other proteins.

TAJ-β inhibitors are synthesized using advanced organic synthesis techniques that allow the precise assembly of molecules with defined structural features. These compounds often feature a combination of hydrophobic and hydrophilic regions that are designed to complement the three-dimensional shape of the TAJ-β protein. Some inhibitors may include functional groups capable of forming strong covalent or non-covalent bonds with the protein's active sites, thereby enhancing their inhibitory potency. The solubility, stability, and reactivity of these inhibitors are carefully considered during their design, as these properties influence how effectively the inhibitor can interact with TAJ-β under different conditions. The diversity in the structural composition of TAJ-β inhibitors allows for the fine-tuning of their binding affinities, making them a valuable class of compounds for studying the biochemical functions and regulatory mechanisms associated with the TAJ-β protein.

Items 1 to 10 of 11 total

Mostrar:

Nome do ProdutoCAS #Numero de CatalogoQuantidadePrecoUso e aplicacaoNOTAS

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$30.00
$125.00
$445.00
45
(1)

Inibe a p38 MAPK, afectando potencialmente as vias de resposta inflamatória em que o TAJ-β pode estar envolvido.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

inibidor da PI3K, poderia perturbar as vias de sinalização importantes para a sobrevivência e proliferação celular.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

inibidor da JNK, pode influenciar as vias de resposta ao stress e a apoptose relacionada com a atividade da TAJ-β.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inibidor da MEK, afectando potencialmente a via MAPK/ERK, o que pode ser relevante para a função do TAJ-β.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Outro inibidor da PI3K poderia ter um impacto adicional nas vias de sinalização em que se supõe que a TAJ-β participa.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

inibidor de mTOR, pode modular o crescimento celular e os processos de autofagia associados ao TAJ-β.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Inibidor da quinase RAF, pode afetar o crescimento celular e as vias de diferenciação que envolvem TAJ-β.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

Inibidor da pan-caspase, que pode influenciar as vias de apoptose que o TAJ-β pode regular.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Inibidor do proteassoma, poderia afetar as vias de degradação de proteínas relevantes para a função do TAJ-β.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modula o NF-κB e outras moléculas de sinalização, afectando potencialmente a inflamação e o crescimento celular.